JOHANNESBURG, Aug 6 (Reuters) – Johnson & Johnson’s COVID-19 vaccine is working well in South Africa, offering protection against severe disease and death, the co-head of a trial in the country said on Friday. The J&J vaccine was administered to healthcare workers from mid-February in a research study, which was completed in May, with 477,234 health workers vaccinated, joint lead investigator Glenda Gray told a media briefing. South Africa’s health regulator approved the J&J shot in April, and it is being used in the national vaccine program alongside Pfizer’s. Gray said the single-shot J&J vaccine offered 91 percent to 96.2 percent protection against death, while offering 67 percent efficac
Hence then, the article about south african study shows high covid protection from j j shot was published today ( ) and is available onEGYPT INDEPENDENT ( Egypt ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( South African study shows high COVID protection from J&J shot )